PositiveDouble Blind Clinical Trial2024
Evaluation of the efficacy, safety, and pharmacokinetics of nanodispersible cannabidiol oral solution (150 mg/mL) versus placebo in mild to moderate anxiety subjects: A double blind multicenter randomized clinical trial
Classification Results
AI Classification
PositiveFine-tuned Classification
Positive